Chang LT

No ORCID on file · 1 paper in corpus · active 2020
2020
Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report.
Journal of ovarian research ·doi:10.1186/s13048-020-00751-3

BackgroundPatients with ovarian clear cell carcinoma (OCCC) have a poor prognosis because they show low sensitivity to platinum-based chemotherapy. New treatments for refractory OCCC are urgently needed.Case presentationWe present a patient…